Navigation Links
Control malaria by segmenting sleeping arrangements
Date:11/18/2013

Better malaria control might come from segregating household sleeping arrangements, according to a new study co-authored by a University of Guelph professor.

The researchers found malaria eradication related more to household size than to a country's wealth or temperature. Guelph economics professor Ross McKitrick and two Finnish professors, Larry and Lena Huldn, found that when average household size drops below four persons, malaria extermination is much more likely.

Malaria is transmitted by infected mosquitoes. The research team examined data on malaria insect vectors, as well as demographic, sociological and environmental factors for 232 countries. Malaria is still prevalent in 106 countries.

"When we controlled for all the variables, the factor that had the most explanatory power on malaria control was household size," said McKitrick.

"Malaria-bearing mosquitoes mainly feed at night, and tend to return to the same location for blood meals. The more people who sleep in one area, the greater the likelihood of an infected mosquito spreading the parasite to a new, uninfected victim."

Malaria infects red blood cells and can cause anemia, nausea, fever and, in some cases, death. Each year, 225 million people are infected and 800,000 die, mostly children.

"It is a common misconception that malaria is a tropical disease, and with 90 per cent of malaria deaths taking place in Africa, it is easy to see why people believe this," said McKitrick.

"But historically, malaria has occurred in all climate zones including the Arctic, and was endemic in North America and Europe a hundred years ago. In many cases, the disease disappeared even in countries that made no efforts to fight it, while others that tried to eradicate it failed. We found declining average household size key to explaining this pattern. "

The researchers looked at factors such as gross domestic product per capita, urbanization and s
'/>"/>

Contact: Ross McKitrick
rmckitri@uoguelph.ca
519-824-4120 x52532
University of Guelph
Source:Eurekalert

Page: 1 2

Related biology news :

1. NIH funds researchers using light to control and monitor neural activity
2. Snakes control blood flow to aid vision
3. Automated system promises precise control of medically induced coma
4. Controlling the triggers of age-related inflammation could extend healthspan
5. Targeted culling of deer controls disease with little effect on hunting
6. Pest control presentations at Entomology 2013
7. Melatonin helps control weight gain as it stimulates the appearance of beige fat
8. Sensors allow for efficient irrigation, give growers more control over plant growth
9. In odd-looking mutant, clues about how maize plants control stem cell number
10. Discovery of cell division master controller may improve understanding and treatment of cancer
11. Drug resistance-associated genes: A cornerstone for the control and protection against tuberculosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... 2015  Unchained Labs just can,t get enough ... Avid Nano. Avid Nano designs, develops and manufactures ... Also today, Unchained Labs UNcaged the ... use protein sizing system. The pUNk is a ... size, size distribution, aggregation population and molecular weight. ...
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
(Date:7/7/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... commerce market announces a revised version of one of its first ... air on CNBC in New York , ... San Francisco metro areas.    ... ability to replace all the cards in your wallet and keep ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... body's natural immune responses could be a target of future cancer ... of Medicine of the University of Southern California. , The ... of Pathology, is the first to identify how EphB4 ?a protein ... important aspect of this study is that ?if we turn the ...
... uncovered a new cellular secret that may explain how ... cancers that makes treatment especially difficult. If the mechanism ... can be understood well enough to manipulate it, new ... metastatic cancers. , Significance of the Mayo Clinic ...
... potentially powerful new therapy for treating diabetes, peripheral vascular ... and into animals by demonstrating it restores nerve and ... particularly important implications for the estimated 21 million Americans ... blood vessels. , The therapy involves netrins, a family ...
Cached Biology News:USC researchers investigate protein that protects tumors 2Mayo Clinic researchers discover cancer cells may move via wave stimulation 2Mayo Clinic researchers discover cancer cells may move via wave stimulation 3Proteins spur diabetic mice models to grow blood vessels, nerves 2
(Date:7/28/2015)... ZIONA, Israel , July ... (TASE:CLPT; OTC:CQPTY), a regenerative medicine company utilizing its ... today announced that Shomrat Shurtz has been appointed ... 2015.      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ... 25 years of experience in marketing, regulatory and ...
(Date:7/27/2015)... and FRANKLIN, Tenn. ... a privately-owned  premier provider of health care services ... in the U.S., today announced that its parent ... signed a definitive agreement with Medical Properties Trust, ... acquisition of Capella for $900 million in cash.  The transaction ...
(Date:7/27/2015)... ... 2015 , ... Production of high tenacity filament yarn of viscose rayon (excluding ... For instance, it surpassed the EUR 106 million mark (in value terms) in 2013, ... a major producer, while Italy is a key consumer. , The high tenacity ...
(Date:7/27/2015)... Research presented at the 2015 AACC Annual Meeting & ... led to a fingerprick Ebola test becoming the first ... approval from the World Health Organization (WHO). This test ... West Africa by identifying suspected Ebola ... and treat these patients much faster than is currently ...
Breaking Biology Technology:CollPlant Names Shomrat Shurtz Senior Director of Business Development 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3
... , Revamilast is a PDE4 inhibitor, under development for ... successfully completed pre-clinical trials and Phase I studies , Phase ... UK , , Glenmark has initiated global  Phase IIb ... unmet medical need as globally they are over 300 million Asthma ...
... QinetiQ North America today announced the results of its ... experiment, which studied the effects of microgravity on host ... results of this experiment showed both the plants and ... (Biological Research In a Canister) homes on the shuttle. ...
... Bharat Renewable Energy Ltd (BREL) , a joint-venture of ... a program with SG Biofuels (SGB) to ... production of biodiesel in India. The program,s ... high performing hybrid varieties of Jatropha adapted to unique ...
Cached Biology Technology:Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule 'Revamilast' 2Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule 'Revamilast' 3Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule 'Revamilast' 4QinetiQ North America Gains New Insights into Plant Growth and Sustainable Life Support on Final Shuttle Flight 2Bharat Renewable Energy Forms Alliance With SG Biofuels to Deploy Jatropha Hybrids for Biodiesel in India 2